4.7 Article

Economic Burdens for Treatment of Patients With Type 2 Diabetes in North Thailand: A Hospital-Based Observational Study

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk A Secondary Analysis of the STRENGTH Trial

Steven E. Nissen et al.

Summary: The study aimed to determine the association between plasma EPA and DHA levels and cardiovascular outcomes in patients at high cardiovascular risk. The results showed that the highest achieved tertiles of EPA and DHA in patients treated with omega-3 carboxylic acid were neither beneficial nor harmful.

JAMA CARDIOLOGY (2021)

Article Medicine, General & Internal

Management of atherosclerosis risk factors for patients at high cardiovascular risk in real-world practice: a multicentre study

Arintaya Phrommintikul et al.

SINGAPORE MEDICAL JOURNAL (2017)

Review Endocrinology & Metabolism

Diabetes in Thailand: Status and Policy

Sirimon Reutrakul et al.

CURRENT DIABETES REPORTS (2016)

Article Economics

Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand

Unchalee Permsuwan et al.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2016)

Review Public, Environmental & Occupational Health

Diabetes management in Thailand: a literature review of the burden, costs, and outcomes

Chaicharn Deerochanawong et al.

GLOBALIZATION AND HEALTH (2013)

Article Endocrinology & Metabolism

Cost of informal care for diabetic patients in Thailand

Susmita Chatterjee et al.

PRIMARY CARE DIABETES (2011)

Article Public, Environmental & Occupational Health

Cost of diabetes and its complications in Thailand: a complete picture of economic burden

Susmita Chatterjee et al.

HEALTH & SOCIAL CARE IN THE COMMUNITY (2011)

Article Endocrinology & Metabolism

Inpatient treatment of diabetic patients in Asia: evidence from India, China, Thailand and Malaysia

J. D. Goldhaber-Fiebert et al.

DIABETIC MEDICINE (2010)

Article Economics

Diabetes cost model of a hospital in Thailand

Arthorn Riewpaiboon et al.

VALUE IN HEALTH (2007)